HOME >> BIOLOGY >> NEWS
Stopping "Cellular Suicide" Could Boost Production In Biotech Labs

Every day, for reasons that are not clearly understood, some human cells commit suicide. Some cells, such as those that have been infected by a virus, kill themselves to preserve the health of the body as a whole. Other self-destruct simply because they sense that a threat to their survival or merely something unfamiliar is lurking nearby.

This process, called apoptosis or programmed cell death, is a normal biological occurrence that can promote proper organ development and help to prevent cancer. But it's unwelcome in modern biotech labs, where scientists turn living cells into miniature pharmaceutical factories that produce proteins, enzymes, antibodies and viruses to help patients with an array of illnesses. Apoptosis prompts many of these microscopic workers to put physiological "guns to their heads" after just a few days on the job. Working closely with molecular biologists, Johns Hopkins University engineer Michael J. Betenbaugh, is trying to disable these guns and allow the drug-making cells to lead longer, more productive lives.

"Ideally, we'd like to extend the lifetime of these cells and increase their efficiency in making biotech products that save people's lives," says Betenbaugh, an associate professor in the Department of Chemical Engineering.

His research has important implications. If scientists find a way to stop cellular suicide, they may be able to keep some cardiac cells from killing themselves after a heart attack. They may also be able to extend the life of artificial organs made from animal tissue.

The key is to halt apoptosis, which is often triggered by changes in a cell's environment. "It may be a viral infection, the loss of a key nutrient, radiation or a chemical toxin--all at sub-lethal levels," Betenbaugh explains. "These would not kill the cell by themselves. Nevertheless, the cell turns on this physiological chain of events that causes it to self-destruct."

In biotech labs, however, researchers want genetically-en
'"/>

Contact: Phil Sneiderman
prs@jhu.edu
410-516-7160
Johns Hopkins University
16-Jul-1997


Page: 1 2 3

Related biology news :

1. Stopping skin cancer Stat3
2. Stopping internal bleeding without surgery
3. Endometriosis: Could angiostatic therapy be the new treatment of the future?
4. Could mice hold the secret to longer life?
5. Could vitamins raise levels of bad cholesterol? Animal study suggests they might
6. Could memory performance and spatial learning be genetically based?
7. Could a specific protein contribute to erectile dysfunction for the diabetic and obese?
8. Could diabetes treatments fight cancer?
9. Could rice be the source for a natural herbicide?
10. Could hibernators hold the key to improving organ preservation?
11. Could Bt transgenic crops have nutritionally favourable effects on insects?

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/10/2020)... ... July 08, 2020 , ... ... and Gene Therapy Regulation, An FDAnews Webinar, Wednesday, July 22, 2020 • 1:30 ... study, but what is the most effective way to complete one? Will the ...
(Date:7/4/2020)... ... , ... Aesthetics Biomedical (ABM), a leading aesthetics product development ... the products and treatments developed, but also the dedicated team behind the brands ... built by ABM have received several honors already for 2020, each of which ...
(Date:7/2/2020)... ... July 02, 2020 , ... ... detailing the use of its revolutionary NEXTGENPCR endpoint thermocycler to test for ... minutes. The article, titled "Ultra-fast one-step RT-PCR protocol for the detection of ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... ... August 11, 2020 , ... The FSHD Society ... Muscular Dystrophy Clinical Trial Research Network (FSHD CTRN), with consideration of ... a consortium of academic research centers in the United States and Europe with ...
(Date:8/12/2020)... BINGHAM FARMS, Mich. (PRWEB) , ... August 12, ... ... International Consulting Group, Inc. (EMMA International), a global leader in FDA compliance ... ranking of the nation’s fastest-growing private companies. The list represents a unique look ...
(Date:8/3/2020)... ... August 03, 2020 , ... ERT, ... President and CEO has been named one of the 100 most inspiring individuals ... PharmaVoice 100 honorees are selected based on how they have inspired their colleagues ...
(Date:7/31/2020)... Ariz. (PRWEB) , ... July 29, 2020 , ... R3 ... joint injections for only $3950. With 50 million stem cells total, patients may choose ... stem cell therapy works for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, ...
Breaking Biology Technology:
Cached News: